NASDAQ
CaliPharms, Inc. (KGET) has a free cash flow growth of -44.61% as of Friday, May 29, 2026. This represents a 91.60% increase compared to its 12-month average of -531.18%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.